cyclosporine


( Last Updated : March 22, 2019)
Generic Name:
cyclosporine
Project Status:
Withdrawn
Therapeutic Area:
keratitis, severe
Manufacturer:
Santen Canada Incorporated
Call for patient/clinician input open:
Brand Name:
Ikervis
Project Line:
Reimbursement Review
Project Number:
SR0518-000
Call for patient/clinician input closed:

Details

Biosimilar:
No
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
keratitis, severe

Key Milestones2

Call for patient input postedApril 17, 2017
Patient group input closedJune 06, 2017
Clarification:

- Patient input submission received

Patient input summary sent for review to patient input groupsJune 26, 2017
Patient group comments on input summary closedJuly 04, 2017
Clarification:

- Patient input summary feedback received

Submission receivedMay 15, 2017
Submission accepted for reviewMay 30, 2017
Review initiatedMay 31, 2017
Clarification:

- Voluntarily withdrawn by the manufacturer on 2017-July-11